A pharmaceutically acceptable salt of a susbtituted pyrrolidine-pyridine –compound
PK140810AUndetermined Publication Date: 2010-06-17INFINITY DISCOVERY INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200801410
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-06-17
Abstract
The present invention relates to a pharmaceutically aceepatable salt of a heterocyclic compound of the formula I that binds to Bel proteins and inhibit Bel function, and compositions comprising such salt of compound for treating and modulating disorders associated with hyperproliferation, such as cancer.
Need to check novelty before this filing date? Find Prior Art